Form D · Hospitals and Physicians
Genesis Oncology Co-Management, LLC
Davenport, IA · CIK 0001546813
Offering snapshot reported Apr 10, 2012 · SEC filing
- Reported sold
- $9K Indefinite offering
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 28, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2012 | Initial | $9,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176448
Source: Form D, filed Apr 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Kovach | Director |
| Sally Werner | Director |
Issuer details
Industry: Hospitals and Physicians (See others in industry)
Address:
1227 E. Rusholme Street
Davenport, IA, 52803
Davenport, IA, 52803